Lymphomatoid papulosis (LyP) is characterised by a chronic course of years to decades of recurrent papulonodular lesions, each of which undergoes spontaneous regression after weeks or months (1) .
Recently LyP type D was identified as a new histolopathological variant simulating a primary cutaneous aggressive epidermotropic CD8 + cytotoxic T-cell lymphoma (pCAE-CD8 + CTCL) (2) . Despite histologically alarming features, the patients have a clinical presentation and indolent course that are similar to those with typical cases of LyP.
CASE REPORT
A 24-year-old Japanese woman with a 10-year history of slightly itchy erythematous papules and plaques on the whole body was referred to our hospital. Individual lesions were self-healing within a few months, even though her papules and plaques never disappeared completely. Although she was initially diagnosed with atopic dermatitis, topical corticosteroids were ineffective.
Physical examination revealed reddish papules and plaques with a crusted surface, and brownish macules, scattered on her trunk, thighs and arms (Fig. 1, upper) . There was neither palpable lymphadenopathy nor hepatosplenomegaly. She reported neither fever nor weight loss. Laboratory data showed no elevated levels of sIL-2R or LDH. PET-CT scanning showed no remarkable FDG uptake, including the lymph nodes and skin lesions. Histopathologically, a biopsy from a plaque on her waist showed prominent epidermotropism. The atypical lymphocytes were characterised by large pleomorphic cells. On immunohistochemical staining, the infiltrating lymphocytes expressed CD3, CD8, CD30, granzyme B and TIA-1 (Fig. 2 ). They were negative for ALK, CD56 and EBER-1. Southern blot analysis showed TCR Vβ/Jβ1 rearrangement. From the combination of clinical, histological, and immunohistochemical features, we diagnosed her as having LyP type D.
The eruptions improved with no active treatment after 7 months, without progression or signs of extracutaneous involvement (Fig. 1, lower) .
DISCUSSION
LyP type D is difficult to differentiate from pCAE-CD8 + CTCL (2). pCAE-CD8 + CTCL is characterised by the rapid onset of plaques and tumours, frequently exhibiting necrosis and ulceration (3) . The clinical course is aggressive, with a median survival of 32 months. Histologically, pCAE-CD8 + CTCL show striking epidermotropism of atypical lymphocytes with a CD8 + cytotoxic phenotype.
Although we initially suspected our patient of having pCAE-CD8 + CTCL, clinical presentation showed waxing and waning papules that resolved spontaneously. Furthermore, we found that the atypical lymphocytes expressed abundant CD30. Therefore, we finally diagnosed our patient as having LyP type D.
As shown in cases of CTCL fulfill immunophenotypic and often histiologic criteria for pCAE-CD8 + CTCL, but follow a benign chronic course without progression or signs of extracutaneous involvement, and have prognosis similar to patch-stage mycosis fungoides (MF). The considerable histologic and immunophenotypic overlap between the more indolent and aggressive cases means that distinction must be made based on clinical features, history of disease course, and results of patient physical examination.
Another possible differential diagnosis of this case is a CD8 + MF or CD30 + MF variant. Prince et al. (5) suggested that the spontaneous remission occurs in MF and Sezary syndrome. Although MF was involved in the differential diagnosis from the clinical features this possibility would be less likely because the degree of epidermotrophism in MF is not so marked (6).
In conclusion, we described LyP type D characterised by striking similarities to pCAE-CD8 + CTCL. Despite histologically alarming features, the patients have an indolent course, as do other variants of typical cases of LyP. The recognition of features of LyP type D is important for the appropriate management of the patients. This variant must be distinguished from the pCAE-CD8 + CTCL to avoid overly aggressive treatment. 
